J. Cosmet. Sci., 64, 175–179 (May/June 2013) 175 Menopause increases the iron storage protein ferritin in skin EDWARD PELLE, JINLONG JIAN, QI ZHANG, NEELAM MUIZZUDDIN, QING YANG, JISEN DAI, DANIEL MAES, NADINE PERNODET, DANIEL B. YAROSH, KRYSTYNA FRENKEL, and XI HUANG, Departments of Medicine and Environmental Medicine, New York University School of Medicine, NY (E.P., J.J., Q.Y., J.D., K.F., X.H.), Estee Lauder Research Laboratories, Melville, NY (E.P., N.M., D.M., N.P., D.B.Y.), and ImClone Systems/Eli Lilly, Branchburg, NJ (Q.Z.). Accepted for publication August 27, 2012. Synopsis Menstruation and desquamation are important routes for humans to excrete iron. Because menstruation is no longer available in postmenopausal women, in the present study, we examined whether iron accumulates more in postmenopausal skin than in premenopausal skin. Skin biopsy samples were obtained from six pre- and six postmenopausal Caucasian women. Iron levels in the form of ferritin were 42% higher, but vascular endothelial growth factor and total antioxidant capacity were 45% and 34% lower in postmenopausal skin (58.8 ±1.3 years old) than in premenopausal skin (41.6 ±1.7 years old), respectively. Moreover, in vitro cultured normal human epidermal keratinocytes had surprisingly high levels of ferritin when compared to immortalized human breast epithelial MCF-10A cells or human liver HepG2 cancer cells. Our results indi- cate that skin is a cellular repository of iron and that menopause increases iron in skin and, thus, may con- tribute to the manifestation of accelerated skin aging and photo aging after menopause. INTRODUCTION Menopause probably has the greatest impact on a woman’s health. Structural and func- tional changes attributable to decreased estrogen as a result of menopause are visibly evi- dent in the skin, which becomes thin and dry with increased wrinkle formation (1). Consequently, the skin becomes more vulnerable to environmental stressors, such as ultraviolet (UV) exposure (2). Previously, we reported that serum ferritin is signifi cantly higher in postmenopausal women than in premenopausal women and is independent of diet or smoking habits (3). Although systemic estrogen decreases because of the cessation of ovarian function, we have recently shown that estrogen downregulates the iron hor- mone hepcidin leading to enhanced iron uptake (4). Thus, estrogen defi ciency does not Address all correspondence to Xi Huang at Xi.Huang@nyumc.org and Edward Pelle at epelle@Estee.com.
JOURNAL OF COSMETIC SCIENCE 176 lead to iron buildup in postmenopausal women, yet iron in the form of ferritin increases as a result of decreasing menstrual periods (5). Ferritin is an iron storage protein that can bind up to 4,500 atoms of iron per molecule of ferritin (3), and increasing evidence shows that ultraviolet A (UVA, 320–400 nm)- induced damage to the skin could be mediated through ferritin (6). For example, we recently found that ferritin sensitized primary human dermal fi broblasts to UVA, which resulted in a signifi cant release of matrix metalloproteinase-1 (MMP-1) (7). Iron is excreted through menstruation and skin desquamation (8). Because postmeno- pausal women no longer menstruate, here we examined whether postmenopausal skin accumulates more ferritin. We further compared ferritin levels in normal human epider- mal keratinocytes (NHEK) to other cell types. MATERIALS AND METHODS HUMAN STUDIES After consent from our institutional review board, clinical subjects were chosen based on a questionnaire that selected for healthy, nonlactating women on a normal American diet. Three millimeter punch human skin biopsies were obtained from six pre- and six post- menopausal Caucasian women by punching the upper, inner left, and inner right arms. After homogenization, the concentration of the protein extracts was determined by the bicinchoninic acid assay (Thermo, Rockford, IL). The remaining protein extracts were used for ferritin, vascular endothelial growth factor (VEGF), and total antioxidant capacity (TAC) analysis. Two data points (left and right arm) per subject were presented in the study. Levels of ferritin were determined by an enzyme-linked immunosorbent assay (ELISA) as previously reported (3). Levels of VEGF were measured using an ELISA kit (Biosource Inc., Camarillo, CA). Levels of TAC were measured using the OxiSelect™ TAC assay kit (Cell Biolab, Inc., San Diego, CA). The results were expressed as nanogram ferritin, pico- gram VEGF, or absorbance [optical density (OD)] per milligram of total protein. CELL CULTURE AND FERRITIN MEASUREMENT IN CELLS NHEK were obtained and cultured in EpiLife® medium (Cascade Biologics, Portland, OR). For comparison, human hepatocarcinoma HepG2 cells with known high levels of ferritin and immortalized human mammary epithelial MCF-10A cells were also tested (ATCC, Manassas, VA). To unify the background levels of ferritin, cells were initially grown in their respective media but subsequently changed to Dulbecco’s Modifi ed Eagle Medium containing 1% fetal bovine serum (FBS) for at least 24 h before ferritin analysis. STATISTICAL ANALYSES All values are expressed as means ± standard deviation (SD). Student’s t tests were used for comparison between experimental groups (p value 0.05).
Purchased for the exclusive use of nofirst nolast (unknown) From: SCC Media Library & Resource Center (library.scconline.org)





























































